Fundraising FoxInnospark Ventures — 2022 Investments
5 investments dated 2022 · listed companies and verified rows first · show all
ArrePath is a biotechnology company that applies AI/ML to drug discovery and development.
AI & Machine LearningBiotechDeep Tech
Zemer Gitai(Founder and SAB Chair)Kevin Krause(President and Chief Executive Officer)
Co-investorsInsight PartnersBoehringer Ingelheim Venture Fund
Entri offers online courses and training programs, including a Montessori teacher certification program.
EdTechBoston, US
Rahul Ramesh(Executive Officer, Director)inMohammed Hisamuddin(Executive Officer, Director)Mohammed Hisam(Founder)inMohammud Peerun(Director)
Co-investors100x Entrepreneur FundGood CapitalInvestopadTrifecta Capital AdvisorsV3 VenturesGokul Rajaram+2 more
Wyebot offers the Wireless Intelligence Platform, an AI-based, vendor-agnostic sensor and software that monitors, analyzes, and automatically identifies problems and solutions for Wi-Fi networks.
AI & Machine LearningEnterprise SoftwareIoTSaaSMarlboro, US
Roger Sands(Co-Founder and Executive Chairman)in
BoardMatthew Rhodes-Kropf(Director)inDavid Baum(Director)inAnil Gupta(Co-Founder and CEO)inDeepak Verma(Director)inSatish Tadikonda(Director)
Co-investorsLaunchCapitalStage 1 VenturesTamiami AngelTectonic VenturesWalnut Venture AssociatesLaunch Capital
Zeta Surgical develops an AI and computer vision-based navigation and robotics platform for image-guided surgery and targeted neuro-therapeutics, enabling high-accuracy image guidance at the point of care.
AI & Machine LearningDeep TechHealthtechMedical DevicesRoboticsBoston, US
Jose Maria Amich(CEO)inRaahil Sha(CTO)inDr. William Gormley(Co-founder)Jose Maria Amich Manero(Executive Officer, Director)Benjamin Lee(Vice President of Product)Hieu Le Mau(Director of Operations)
Co-investorsAirTree VenturesArtesianBrincEmles Venture PartnersParticleTSVC+8 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Text Mercato
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.